Nav: Home

New role in spatial chromosome organization identified for often mutated cancer protein

May 22, 2019

PHILADELPHIA -- (May 22, 2019) -- New research from The Wistar Institute sheds light on the function of the ARID1A protein, encoded by a gene that is among the most frequently mutated across human cancers. According to the study, published online in Science Advances, ARID1A plays a role in the spatial organization of the genome; therefore, its loss has broad effects on global gene expression. This finding adds critical information towards deciphering the molecular alterations associated with several cancer types and especially with ovarian cancer.

"My lab has been studying the role of ARID1A in gene expression regulation as part of a complex known as SWI/SNF," said principal investigator Rugang Zhang, Ph.D., deputy director of The Wistar Institute Cancer Center, and professor and co-program leader of the Gene Expression and Regulation Program. "In our search for new interacting proteins of this complex, we discovered one that offers new perspectives on the function of ARID1A as a genome-wide regulator of spatial chromosome organization."

The three-dimensional organization of the genome dictates how several feet worth of DNA molecules are packed in a microscopic space while also allowing each gene to be accessible for transcription and expression at the appropriate time. The team found that ARID1A interacts with a component of the condensin II complex, which regulates gene expression through organizing chromosome structure.

"This is a finely regulated process and we revealed that ARID1A has a critical role in it," added Zhang.

Results showed that ARID1A dictates the genome-wide positioning of condensin II on certain DNA regulatory elements called enhancers. Therefore, when ARID1A function is lost as a consequence of gene mutation, condensin II distribution is altered and so is expression of a large set of genes.

Zhang and colleagues also revealed that, through its interaction with condensin II, ARID1A controls how different parts of chromosomes are spatially organized together in regions known as chromosomal territories that facilitate the coordinated expression of certain sets of genes.

"Our findings add an important piece to the field of chromatin regulation in cancer," said Shuai Wu, Ph.D., co-first author of the study and a postdoctoral researcher in the Zhang Lab. "By altering the special organization of chromosomes, ARID1A loss is expected to have much broader consequences on gene expression than we originally thought."
Co-authors: Co-first author Nail Fatkhutdinov, Osamu Iwasaki, Hideki Tanizawa, Hsin-Yao Tang, Andrew V. Kossenkov, Alessandro Gardini, Ken-ichi Noma, and David W. Speicher from Wistar; Leah Rosin, Jennifer M. Luppino, and Eric F. Joyce from the University of Pennsylvania Perelman School of Medicine.

Work supported by: National Institutes of Health (NIH) grants R01CA160331, R01CA163377, R01CA202919, P01AG031862, R35GM128903, R50CA221838, and R50CA211199; U.S. Department of Defense grants OC140632P1 and OC150446. Core support for The Wistar Institute was provided by the Cancer Center Support Grant P30CA010815.

Publication information: ARID1A spatially partitions interphase chromosomes, Science Advances (2019). Advance online publication.

The Wistar Institute is an international leader in biomedical research with special expertise in cancer, immunology, infectious disease research, and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the United States, Wistar has held the prestigious Cancer Center designation from the National Cancer Institute since 1972. The Institute works actively to ensure that research advances move from the laboratory to the clinic as quickly as possible.

The Wistar Institute

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
More Cancer News and Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#534 Bacteria are Coming for Your OJ
What makes breakfast, breakfast? Well, according to every movie and TV show we've ever seen, a big glass of orange juice is basically required. But our morning grapefruit might be in danger. Why? Citrus greening, a bacteria carried by a bug, has infected 90% of the citrus groves in Florida. It's coming for your OJ. We'll talk with University of Maryland plant virologist Anne Simon about ways to stop the citrus killer, and with science writer and journalist Maryn McKenna about why throwing antibiotics at the problem is probably not the solution. Related links: A Review of the Citrus Greening...